At close: 2:00:03 PM GMT+1
Key Executives
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Hugo Brugiere M.Sc. | Chairman, GM & CEO | 85k | -- | -- |
| Prof. Daniel Zagury | Founder, Chairman of Scientific Research Committee & Director | 6k | -- | -- |
| Mr. Vincent Serra Ph.D. | Scientific & Operational Director | 188.8k | -- | 1970 |
| Mr. Alexandre Courtoux | Administrative & Financial Director | -- | -- | -- |
| Charlene Masson | Corporate Communication & Investor Relations | -- | -- | -- |
Neovacs S.A.
3-5, Impasse Reille
Paris, 75014
France
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 22
Description
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of dermatomyositis; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company was founded in 1993 and is based in Paris, France.
Corporate Governance
Neovacs S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ALVIO.PA Valerio Therapeutics Société anonyme
0.0750
-5.06%
ALTHX.PA Theranexus Société Anonyme
0.5800
-2.68%
SIGHT.PA GenSight Biologics S.A.
0.2715
-1.63%
ADOC.PA Adocia SA
5.98
+1.01%
SAR.L Sareum Holdings plc
27.00
0.00%
DBV.PA DBV Technologies S.A.
0.6190
-1.28%
GNFT.PA Genfit S.A.
3.4800
+0.29%
ZIVO ZIVO Bioscience, Inc.
22.10
+22.78%
ONVO Organovo Holdings, Inc.
0.3401
-1.47%
XERS Xeris Biopharma Holdings, Inc.
3.4750
+1.61%